COMPANY
BRAINBox Solutions
BRAINBox Solutions is listed on ClinicalTrials.gov as the lead sponsor of 1 study; the most recently updated is “HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma” (unknown), in Mild Traumatic Brain Injury. BRAINBox Solutions has received NIH funding, most recently in fiscal 2022 for the project “Multi-modality Test for improving precision of TBI diagnosis in the elderly”. From public records Source · Oct 12, 2026
Timeline
Funding
- Private equity round: amount not published, announced Aug 4, 2026. Source: company's own press page. source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04423198 | HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma | Not listed | Unknown status (ClinicalTrials.gov) | Dec 31, 2020 | 2021-12 (estimated) |
NIH awards 1
- NIH award 1R44NS127732-01 FY2022: $471,835 awarded for that fiscal year; activity R44 (SBIR); PI VAN METER, TIMOTHY E; recipient as written: BRAINBOX SOLUTIONS, INC., RICHMOND, VA. Multi-modality Test for improving p source ↗